AHA Post Conference Perspectives: Emerging Therapies in Hypertrophic Cardiomyopathy (HCM)

home / post-conference-perspectives / aha-post-conference-perspectives-emerging-therapies-in-hypertrophic-cardiomyopathy-hcm-

An expert in the management of hypertrophic cardiomyopathy discusses the burden of disease, existing treatment options, unmet needs, and explores data from an emerging class of agents, myosin inhibitors.

Episodes

January 11th 2021EP. 1: HCM Overview and Presenting Symptoms

January 11th 2021EP. 2: The Diagnosis of Hypertrophic Cardiomyopathy

January 11th 2021EP. 3: Patient Burden: Healthcare Resources and Complications

January 11th 2021EP. 4: Future of HCM: Allosteric Inhibitors of Cardiac Myosin

January 11th 2021EP. 5: Promising Myosin Inhibitor Findings Presented at AHA

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions